Related Experiment Video
Updated: Feb 27, 2026

A Mouse Fetal Skin Model of Scarless Wound Repair
Published on: January 16, 2015
Pediatric Skin Failure
Katie E Cohen1, Matthew C Scanlon1, Amin Bemanian1
1Katie E. Cohen is a medical student, Matthew C. Scanlon is a professor of pediatrics, and Amin Bemanian is a medical student at the Medical College of Wisconsin, Milwaukee, Wisconsin. Christine A. Schindler is a clinical assistant professor, College of Nursing, Marquette University, Milwaukee, Wisconsin.
Insights
Critically ill children with severe organ dysfunction may experience acute skin failure, not preventable pressure ulcers. This condition, linked to multiple organ dysfunction syndrome (MODS), has a high mortality rate in pediatric intensive care units.
Area of Science:
- Pediatric critical care medicine
- Dermatology
- Pathophysiology of critical illness
Background:
- Skin failure is recognized in adults but often misclassified as pressure ulcers in children.
- Current pediatric literature indiscriminately groups severe skin injuries as pressure ulcers.
Purpose of the Study:
- To identify and characterize the phenomenon of acute skin failure in critically ill pediatric patients.
- To differentiate acute skin failure from traditional pressure ulcers in this population.
Main Methods:
- Retrospective chart review of 19 pediatric patients with serious skin injuries.
- Analysis of organ dysfunction scores, medications, pressure ulcer prevention, and laboratory values preceding skin lesion development.
Main Results:
- All patients had preventive measures in place; injuries were full-thickness upon identification.
- 18/19 patients had multiple organ dysfunction syndrome (MODS) with at least 2 dysfunctional systems.
- Mortality rate was 42% in this cohort, significantly higher than the general pediatric intensive care unit population (1.8%).
Conclusions:
- A subset of severe skin injuries in critically ill children may represent acute skin failure secondary to MODS.
- This challenges the traditional view of pressure ulcers as entirely preventable in this vulnerable group.
Background:
The phenomenon of skin failure as distinct from pressure ulcers has been documented in the adult literature. However, in the pediatric population, skin injury continues to be grouped indiscriminately as various types of pressure ulcers.
Objective:
To identify and describe the phenomenon of skin failure in critically ill children.
Methods:
Retrospective chart review of 19 patients who had serious skin injuries develop. Organ dysfunction scores, medications, pressure ulcer prevention techniques used, and laboratory values in the 7 days leading up to the development of a skin lesion were evaluated.
Results:
At the start of the evaluation period, all patients (N = 19) had pressure ulcer prevention measures in place before the development of a serious skin injury. All of the skin lesions were full-thickness injuries on the day they were identified (as opposed to the more gradual progression from simple to complex skin injuries typically seen in pressure ulcers). As predicted, 18 of 19 patients had multiple organ dysfunction syndrome (MODS) in the week leading up to the skin injury. All patients with MODS had at least 2 dysfunctional systems, and 12 patients had 4 or more dysfunctional systems. Of the 19 patients, 8 (42%) progressed to death, compared with 1.8% in our general pediatric intensive care unit population.
Conclusion:
Although the traditional paradigm is that pressure ulcers are preventable, a subset of pressure ulcers in critically ill children may actually represent acute skin failure as a consequence of MODS.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution
Clinical Applications of Epidermal Stem Cells

